Novo Nordisk Investigational Site is a clinical research site located in Columbia, South Carolina, United States 29203.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Novo Nordisk Investigational Site has participated in 13 clinical trials.
Therapeutic areas: Diabetes, Diabetes Mellitus, Type 2, Metabolism and Nutrition Disorder.
Sponsors: Novo Nordisk A/S.
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Novo Nordisk Investigational Site has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Novo Nordisk Investigational Site has 13 clinical trials on record. Their work covers Diabetes, Diabetes Mellitus, Type 2, Metabolism and Nutrition Disorder.
Yes — Novo Nordisk Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.